Oncological outcome of fat grafting for breast reconstruction after cancer
Gaia Griguolo(University of North Carolina at Chapel Hill), Valentina Guarneri(Istituto Oncologico Veneto), Grazia Maria Vernaci(University of Padua), De Antoni E(University of Padua), Alberto Marchet(Istituto Oncologico Veneto), Esra Baldan(Istituto Oncologico Veneto), Silvia Michieletto(Istituto Oncologico Veneto), Ilaria Polico(Istituti di Ricovero e Cura a Carattere Scientifico), Franco Bassetto(University of Padua), Maria Vittoria Dieci(Istituto Oncologico Veneto), Vincenzo Vindigni(University of Padua), Tania Saibene(Istituti di Ricovero e Cura a Carattere Scientifico), Federica Miglietta(University of Padua)
Cited by 0
Related Papers
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast Cancer
|Journal of Clinical Oncology|2007|290
Evolution of HER2-low expression from primary to recurrent breast cancer
|npj Breast Cancer|2021|226